New Antibody Armanezumab May Be Possible Therapeutic Strategy for ALS
Researchers have developed an antibody, called armanezumab, which specifically targets defective tau protein. The molecule has potential for the treatment…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Researchers have developed an antibody, called armanezumab, which specifically targets defective tau protein. The molecule has potential for the treatment…
Researchers report that evaluating a person’s control of tongue movement during speech can help to diagnose bulbar disease, especially in its early…
Recent research identified molecules in the cerebrospinal fluid of people with amyotrophic lateral sclerosis, particularly phosphorylated neurofilament heavy chain (pNfH), to…